EPIRUS Biopharmaceuticals, Inc. Share-based Payment Arrangement, Expense
EPIRUS Biopharmaceuticals, Inc. reported Share-based Payment Arrangement, Expense of $2.00 million for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2016-05-10
- EPIRUS Biopharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2016-03-31 was $2.00M, a 280.04% increase year-over-year.
- EPIRUS Biopharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2015-12-31 was $1.20M, a 197.04% increase year-over-year.
- EPIRUS Biopharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2015-09-30 was $898.00K, a 4.77% decline year-over-year.
- EPIRUS Biopharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2015-06-30 was $843.00K, a 157.80% increase year-over-year.
- EPIRUS Biopharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2015 was $3.47M, a 101.86% increase from fiscal 2014.
- EPIRUS Biopharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2014 was $1.72M, a 1127.86% increase from fiscal 2013.
- EPIRUS Biopharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2013 was $140.00K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2016-03-31 | $2.00M 10-Q · filed 2016-05-10 | $3.20M derived: sum of 2 quarters · filed 2016-05-10 | $4.10M derived: sum of 3 quarters · filed 2016-05-10 | $4.94M derived: sum of 4 quarters · filed 2016-05-10 |
| 2015-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $2.10M derived: sum of 2 quarters · filed 2016-03-29 | $2.94M derived: sum of 3 quarters · filed 2016-03-29 | $3.47M 10-K · filed 2016-03-29 |
| 2015-09-30 | $898.00K 10-Q · filed 2015-11-16 | $1.74M derived: sum of 2 quarters · filed 2015-11-16 | $2.27M 10-Q · filed 2015-11-16 | $2.67M derived: sum of 4 quarters · filed 2016-05-10 |
| 2015-06-30 | $843.00K 10-Q · filed 2015-08-12 | $1.37M 10-Q · filed 2015-08-12 | $1.77M derived: sum of 3 quarters · filed 2016-05-10 | $2.72M derived: sum of 4 quarters · filed 2016-05-10 |
| 2015-03-31 | $526.00K 10-Q · filed 2016-05-10 | $931.00K derived: sum of 2 quarters · filed 2016-05-10 | $1.87M derived: sum of 3 quarters · filed 2016-05-10 | $2.20M derived: sum of 4 quarters · filed 2016-05-10 |
| 2014-12-31 | $405.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $1.35M derived: sum of 2 quarters · filed 2016-03-29 | $1.68M derived: sum of 3 quarters · filed 2016-03-29 | $1.72M 10-K · filed 2016-03-29 |
| 2014-09-30 | $943.00K 10-Q · filed 2015-11-16 | $1.27M derived: sum of 2 quarters · filed 2015-11-16 | $1.31M 10-Q · filed 2015-11-16 | $1.36M derived: sum of 4 quarters · filed 2015-11-16 |
| 2014-06-30 | $327.00K 10-Q · filed 2015-08-12 | $371.00K 10-Q · filed 2015-08-12 | $418.00K derived: sum of 3 quarters · filed 2015-08-12 | $453.00K derived: sum of 4 quarters · filed 2015-08-12 |
| 2014-03-31 | $44.00K 10-Q · filed 2015-05-13 | $91.00K derived: sum of 2 quarters · filed 2015-05-13 | $126.00K derived: sum of 3 quarters · filed 2015-05-13 | |
| 2013-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $82.00K derived: sum of 2 quarters · filed 2015-03-31 | $140.00K 10-K · filed 2015-03-31 | |
| 2013-09-30 | $35.00K 10-Q · filed 2014-11-10 | $93.00K 10-Q · filed 2014-11-10 | ||
| 2012-09-30 | $489.00K 10-Q · filed 2012-11-08 | $948.00K derived: sum of 2 quarters · filed 2012-11-08 | $1.46M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $459.00K 10-Q · filed 2012-08-07 | $968.00K 10-Q · filed 2012-08-07 | ||
| 2011-09-30 | $548.00K 10-Q · filed 2012-11-08 | $1.17M derived: sum of 2 quarters · filed 2012-11-08 | $1.69M 10-Q · filed 2012-11-08 | |
| 2011-06-30 | $623.00K 10-Q · filed 2012-08-07 | $1.41M 10-Q · filed 2012-08-07 |